[{"id":"e5b1a6c3-e729-4a52-a992-a915116be9cb","acronym":"CisCon","url":"https://clinicaltrials.gov/study/NCT05406674","created_at":"2022-06-06T12:57:31.984Z","updated_at":"2024-07-02T16:35:34.440Z","phase":"Phase 2","brief_title":"Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer","source_id_and_acronym":"NCT05406674 - CisCon","lead_sponsor":"The Netherlands Cancer Institute","biomarkers":" KRT7 • KRT20 • PAX8","pipe":"","alterations":" ","tags":["KRT7 • KRT20 • PAX8"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin"],"overall_status":"Recruiting","enrollment":" Enrollment 40","initiation":"Initiation: 06/15/2022","start_date":" 06/15/2022","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-10-06"}]